Regulation of angiogenic factors by HDM2 in renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-01-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-06-4738PMID 18199551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.

  2007cited by this paper
• Selective inhibition of MEK1/2 reveals a differential requirement for ERK1/2 signalling in the regulation of HIF-1 in response to hypoxia and IGF-1

  2007cited by this paper
• Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.

  2007cited by this paper
• Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

  2007cited by this paper
• Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.

  2006cited by this paper
• Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma

  2005cited by this paper
• Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels.

  2005cited by this paper
• The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

  2005cited by this paper
• p53 regulation and function in renal cell carcinoma.

  2005cited by this paper
• MEK-ERK Signaling Controls Hdm2 Oncoprotein Expression by Regulating hdm2 mRNA Export to the Cytoplasm*

  2005cited by this paper
• The von Hippel-Lindau protein, HIF hydroxylation, and oxygen sensing.

  2005cited by this paper
• Mdm2 and HIF-1alpha interaction in tumor cells during hypoxia.

  2005cited by this paper
• Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways

  2005cited by this paper
• Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.

  2005cited by this paper
• p53-independent activities of MDM2 and their relevance to cancer therapy.

  2005cited by this paper
• Mdm2 and HIF‐1α interaction in tumor cells during hypoxia

  2005cited by this paper
• Novel Function of Orphan Nuclear Receptor Nur77 in Stabilizing Hypoxia-inducible Factor-1α*

  2004cited by this paper
• Role of VHL gene mutation in human cancer.

  2004cited by this paper
• Growth Factor-Mediated Induction of HDM2 Positively Regulates Hypoxia-Inducible Factor 1α Expression

  2004cited by this paper
• Vascular Endothelial Growth Factor Transcriptional Activation Is Mediated by Hypoxia-inducible Factor 1α, HDM2, and p70S6K1 in Response to Phosphatidylinositol 3-Kinase/AKT Signaling*

  2004cited by this paper
• p53 Pathway in Renal Cell Carcinoma Is Repressed by a Dominant Mechanism

  2004cited by this paper
• The Plasminogen Activator Inhibitor-1 Gene Is Induced by Cell Adhesion through the MEK/ERK Pathway

  2003cited by this paper
• Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.

  2003cited by this paper
• Direct Interactions between HIF-1α and Mdm2 Modulate p53 Function*

  2003cited by this paper
• MDM2, an introduction.

  2003cited by this paper
• Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function.

  2003cited by this paper
• Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy

  2003cited by this paper
• Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

  2002cited by this paper
• Phosphorylation of HDM2 by Akt

  2002cited by this paper
• A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression

  2001cited by this paper
• Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

  2000cited by this paper
• Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.

  2000cited by this paper
• Stress Signals Utilize Multiple Pathways To Stabilize p53

  2000cited by this paper
• Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.

  2000cited by this paper
• Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

  2000cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999cited by this paper
• Mdm2 promotes the rapid degradation of p53

  1997cited by this paper
• Regulation of p53 stability by Mdm2

  1997cited by this paper
• Tumour suppression by the human von Hippel-Lindau gene product

  1995cited by this paper
• Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.

  1995cited by this paper

• Genetic Variations in MDM2 Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype–Phenotype Correlation Study

  2025cites this paper
• Exercise-induced angiogenesis and lymphangiogenesis: A potential therapeutic tool to fight aging and disease

  2025cites this paper
• Dysregulation of ubiquitination modification in renal cell carcinoma

  2024cites this paper
• The Underestimated Role of the p53 Pathway in Renal Cancer

  2022cites this paper
• Helicobacter pylori promotes epithelial-to-mesenchymal transition by downregulating CK2β in gastric cancer cells.

  2022cites this paper
• Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy

  2022cites this paper
• Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

  2021cites this paper
• VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function

  2018cites this paper
• Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function

  2017cites this paper
• Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment.

  2016cites this paper
• The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

  2016cites this paper
• Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo

  2016cites this paper
• Loss of Diacylglycerol Kinase-Ζ Inhibits Cell Proliferation and Survival in Human Gliomas

  2016cites this paper
• Hyperbaric oxygen therapy activates hypoxia‐inducible factor 1 (HIF‐1), which contributes to improved wound healing in diabetic mice

  2015cites this paper
• MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data

  2015cites this paper
• Regulation of skeletal muscle capillary growth in exercise and disease.

  2015cites this paper
• Rôle de la voie sphingosine kinase 1/sphingosine 1-phosphate dans l'adaptation à l'hypoxie intratumorale des adénocarcinomes rénaux à cellules claires

  2015influential citation
• Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

  2015cites this paper
• Pro-angiogenic effects of MDM2 through HIF-1α and NF-κB mediated mechanisms in LNCaP prostate cancer cells

  2014cites this paper
• New agents and new targets for renal cell carcinoma.

  2014cites this paper
• Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism.

  2014cites this paper
• Targeting MDM2-p53 interaction for cancer therapy: are we there yet?

  2014cites this paper
• Crosstalk between Mdm2, p53 and HIF1-α: distinct responses to oxygen stress and implications for tumour hypoxia.

  2014influential citation
• MDM4 expression as an indicator of TP53 reactivation by combined targeting of MDM2 and MDM4 in cancer cells without TP53 mutation

  2014cites this paper
• Oxygen-sensing and Mitochondrial Control of Cell Function

  2013cites this paper
• Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer

  2013cites this paper
• Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma

  2013cites this paper
• Novel perspective: exercise training stimulus triggers the expression of the oncoprotein human double minute-2 in human skeletal muscle

  2013cites this paper
• Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways

  2013cites this paper
• Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy

  2012cites this paper
• Natural product MDM2 inhibitors: anticancer activity and mechanisms of action.

  2012cites this paper
• New pathogenic mechanisms in diabetic wound healing

  2012cites this paper
• Murine double minute‐2 expression is required for capillary maintenance and exercise‐induced angiogenesis in skeletal muscle

  2012cites this paper
• MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.

  2011cites this paper
• Targeting the Tumor Microenvironment: Focus on Angiogenesis

  2011cites this paper
• The antagonism between MCT-1 and p53 affects the tumorigenic outcomes

  2010cites this paper
• Hdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERT

  2010cites this paper
• HIF‐1 Inhibitors for Cancer Therapy

  2010cites this paper
• p53 and MDM2 in renal cell carcinoma

  2010cites this paper
• Activated extracellular signal‐regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma

  2009cites this paper
• Recent advances in validating MDM2 as a cancer target.

  2009cites this paper
• Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

  2009cites this paper
• Oxygen-dependent Regulation of HIF-1alpha Expression and Function

  2009cites this paper
• Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells

  2009cites this paper
• Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.

  2009cites this paper
• Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells

  2009cites this paper
• Loss of Heterozygosity Predicts Poor Survival After Resection of Pancreatic Adenocarcinoma

  2008cites this paper
• Rowan Digital Works Rowan Digital Works

  year unknowncites this paper